Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases
- PMID: 17496916
- DOI: 10.1038/sj.onc.1210412
Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases
Abstract
The regulated dephosphorylation of mitogen-activated protein kinases (MAPKs) plays a key role in determining the magnitude and duration of kinase activation and hence the physiological outcome of signalling. In mammalian cells, an important component of this control is mediated by the differential expression and activities of a family of 10 dual-specificity (Thr/Tyr) MAPK phosphatases (MKPs). These enzymes share a common structure in which MAPK substrate recognition is determined by sequences within an amino-terminal non-catalytic domain whereas MAPK binding often leads to a conformational change within the C-terminal catalytic domain resulting in increased enzyme activity. MKPs can either recognize and inactivate a single class of MAP kinase, as in the specific inactivation of extracellular signal regulated kinase (ERK) by the cytoplasmic phosphatase DUSP6/MKP-3 or can regulate more than one MAPK pathway as illustrated by the ability of DUSP1/MKP-1 to dephosphorylate ERK, c-Jun amino-terminal kinase and p38 in the cell nucleus. These properties, coupled with transcriptional regulation of MKP expression in response to stimuli that activate MAPK signalling, suggest a complex negative regulatory network in which individual MAPK activities can be subject to negative feedback control, but also raise the possibility that signalling through multiple MAPK pathways may be integrated at the level of regulation by MKPs.
Similar articles
-
Diverse physiological functions for dual-specificity MAP kinase phosphatases.J Cell Sci. 2006 Nov 15;119(Pt 22):4607-15. doi: 10.1242/jcs.03266. J Cell Sci. 2006. PMID: 17093265 Review.
-
Expression of mitogen-activated protein kinase phosphatase 1, a negative regulator of the mitogen-activated protein kinases, in rheumatoid arthritis: up-regulation by interleukin-1beta and glucocorticoids.Arthritis Rheum. 2004 Oct;50(10):3118-28. doi: 10.1002/art.20580. Arthritis Rheum. 2004. PMID: 15476200
-
Functional assignment of MAPK phosphatase domains.Proteins. 2007 Oct 1;69(1):19-31. doi: 10.1002/prot.21477. Proteins. 2007. PMID: 17596826
-
Role of MAP kinase phosphatases in GnRH-dependent activation of MAP kinases.J Mol Endocrinol. 2006 Feb;36(1):41-50. doi: 10.1677/jme.1.01881. J Mol Endocrinol. 2006. PMID: 16461925
-
Structure and regulation of MAPK phosphatases.Cell Signal. 2004 Jul;16(7):769-79. doi: 10.1016/j.cellsig.2003.12.008. Cell Signal. 2004. PMID: 15115656 Review.
Cited by
-
The roles of phosphorylation of signaling proteins in the prognosis of acute myeloid leukemia.Pathol Oncol Res. 2024 Jul 5;30:1611747. doi: 10.3389/pore.2024.1611747. eCollection 2024. Pathol Oncol Res. 2024. PMID: 39035053 Free PMC article.
-
Identification of PTPN12 Phosphatase as a Novel Negative Regulator of Hippo Pathway Effectors YAP/TAZ in Breast Cancer.Int J Mol Sci. 2024 Apr 5;25(7):4064. doi: 10.3390/ijms25074064. Int J Mol Sci. 2024. PMID: 38612874 Free PMC article.
-
Human nonunion tissues display differential gene expression in comparison to physiological fracture callus.Bone. 2024 Jun;183:117091. doi: 10.1016/j.bone.2024.117091. Epub 2024 Apr 2. Bone. 2024. PMID: 38570121
-
MAPK phosphatase 1 inhibition of p38α within lung myofibroblasts is essential for spontaneous fibrosis resolution.J Clin Invest. 2024 Mar 21;134(10):e172826. doi: 10.1172/JCI172826. J Clin Invest. 2024. PMID: 38512415 Free PMC article.
-
Effects of an in vitro vitamin D treatment on the inflammatory responses in visceral adipose tissue from Ldlr-/- mice.Nutr Res Pract. 2024 Feb;18(1):19-32. doi: 10.4162/nrp.2024.18.1.19. Epub 2023 Dec 11. Nutr Res Pract. 2024. PMID: 38352213 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous